Skip to Content

UK Edition. Click here for US version.

BEACITA 120MG CAPSULES HARD

Active substance(s): ORLISTAT

View full screen / Print PDF » Download PDF ⇩
Transcript
PACKAGE LEAFLET: INFORMATION FOR THE USER

Beacita 120mg Capsules, hard
Orlistat

Read all of this leaflet carefully before you start taking this medicine because it contains important
information for you.
• Keep this leaflet. You may need to read it again.
• If you have any further questions, please ask your doctor, pharmacist or nurse.
• This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if
their signs of illness are the same as yours.
• If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects
not listed in this leaflet. See section 4.
What is in this leaflet:
1. What Beacita is and what it is used for
2. What you need to know before you take Beacita
3. How to take Beacita
4. Possible side effects
5. How to store Beacita
6. Contents of the pack and other information

1. WHAT BEACITA IS AND WHAT IT IS USED FOR
Beacita is a medicine used to treat obesity. It works in your digestive system to block about one-third of the
fat in the food you eat from being digested.
Beacita attaches to the enzymes in your digestive system (lipases) and blocks them from breaking down
some of the fat you have eaten during your meal. The undigested fat cannot be absorbed and is eliminated
by your body.
Beacita is indicated in the treatment of obesity in conjunction with a low calorie intake diet.

2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE BEACITA
Do not take Beacita:
• if you are allergic to orlistat or any of the other ingredients of this medicine (listed in section 6)
• if you have chronic malabsorption syndrome (insufficient absorption of nutrients across the
gastrointestinal (GI) tract)
• if you have cholestasis (liver disorder)
• if you are breast-feeding.
Warnings and precautions
Weight loss may also affect the dose of medicines taken for other conditions (e.g. high cholesterol or
diabetes). Be sure to discuss these and other medicines you may be taking with your doctor. Losing weight
may mean you need adjustments to the dose of these medicines.
To gain the maximum benefit from Beacita you should follow the nutrition program recommended to you
by your doctor. As with any weight-control program, over-consumption of fat and calories may reduce any
weight loss effect.
This medicine can cause harmless changes in your bowel habits, such as fatty or oily stools, due to the
elimination of undigested fat in your faeces. The possibility of this happening may increase if Beacita is
taken with a diet high in fat. In addition your daily intake of fat should be distributed evenly over three main
meals because if Beacita is taken with a meal very high in fat, the possibility of gastrointestinal effects may
increase.
The use of an additional contraceptive method is recommended to prevent possible failure of oral
contraception that could occur in case of severe diarrhoea.
The use of orlistat may be associated with renal stones in patients suffering from chronic kidney disease.
Inform your doctor whether you suffer from problems with your kidney.
Children and adolescents
Beacita is not intended to be used in children and adolescents below 18 years.
Other medicines and Beacita
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines,
even those not prescribed. This is important as using more than one medicine at the same time can
strengthen or weaken the effects of the medicines.
Beacita may modify the activity of:
• acarbose. Beacita is not recommended for people taking acarbose (an anti-diabetic drug used to treat
type 2 diabetes mellitus).
• anticoagulant drugs (e.g. warfarin). Your doctor may need to monitor your blood coagulation.
• ciclosporin (medicine dampening down the body’s immune system). Co-administration with Beacita
is not recommended. However, if such use is unavoidable, your doctor may need to monitor your
ciclosporin blood levels more frequently than usual.
• iodine salts and/or levothyroxine. Cases of hypothyroidism and/or reduced control of hypothyroidism
may occur.
• amiodarone (medicine used for irregular heart beat). You may ask your doctor for advice.
• 
medicines to treat HIV.
• medicines for depression, psychiatric disorders or anxiousness
Beacita reduces the absorption of supplements of some fat soluble nutrients, particularly beta-carotene
and vitamin E. You should therefore follow your doctor’s advice in taking a well balanced diet rich in fruit
and vegetables and in taking a multivitamin supplement.
Beacita may unbalance an anticonvulsant treatment, by decreasing the absorption of antiepileptic drugs,
thus leading to convulsions. Please contact your doctor if you think that the frequency and/or severity of
the convulsions have changed when taking Beacita together with antiepileptic drugs.
Beacita should be used with caution in patients treated with antidepressants and antipsychotics (including
lithium).
Beacita with food and drink
Beacita can be taken immediately before, during a meal or up to one hour after a meal. The capsule should
be swallowed with water.
Pregnancy and breast-feeding
Taking Beacita during pregnancy is not recommended.
You must not breast-feed your infant during treatment with Beacita as it is not known whether Beacita
passes into human milk.
Driving and using machines
Beacita has no known effect on your ability to drive a car or operate machinery.

3. HOW TO TAKE BEACITA
Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you
are not sure.
Dose:
The recommended dose of Beacita is one 120mg capsule taken with each of the three main meals per day.
It can be taken immediately before, during a meal or up to one hour after a meal. The capsule should be
swallowed with water.
General information:
Beacita should be taken with a well-balanced, calorie controlled diet that is rich in fruit and vegetables
and contains an average of 30% of the calories from fat. Your daily intake of fat, carbohydrate and protein
should be distributed over three meals. This means you will usually take one capsule at breakfast time, one
capsule at lunch time and one capsule at dinner time. To gain optimal benefit, avoid the intake of food
containing fat between meals, such as biscuits, chocolate and savoury snacks.
Beacita only works in the presence of dietary fat. Therefore, if you miss a main meal or if you have a meal
containing no fat, Beacita does not need to be taken.
AAAI5716

Orlistat 120 mg Capsules PIL UK

1. black

item no:

AAAI5716

dimensions: 150 x 400

print proof no:

2

pharmacode:

origination date: 3.12.15
approved for print/date

colours/plates:

min pt size:

2.
3.
4.

8 pt

originated by:

db

revision date:

23.12.15

Technical Approval

revised by:

db

date sent:

3.12.15

supplier:

Farmaprojects

approved:

23.12.15

5.
6.
Non Printing Colours
1.
2.
3.

Tell your doctor if, for any reason, you have not taken your medicine exactly as prescribed. Otherwise, your
doctor may think that it was not effective or well tolerated and may change your treatment unnecessarily.
Your doctor will discontinue the treatment with Beacita after 12 weeks if you have not lost at least 5% of
your body weight as measured at the start of treatment with Beacita.
Beacita has been studied in long-term clinical studies of up to 4 years duration.
If you take more Beacita than you should
If you take more capsules than you have been told to take, or if someone else accidentally takes your
medicine, contact a doctor, pharmacist or hospital immediately as you may need medical attention.
If you forget to take Beacita
If you forget to take your medicine at any time, take it as soon as you remember provided this is within one
hour of your last meal, then continue to take it at the usual times. Do not take a double dose to make up for
a forgotten one. If you have missed several doses, please inform your doctor and follow the advice given to
you.
Do not change the prescribed dose yourself unless your doctor tells you to.
If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.

4. POSSIBLE SIDE EFFECTS
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Tell your doctor or pharmacist as soon as possible if you do not feel well while you are taking Beacita.
The majority of unwanted effects related to the use of Beacita result from its local action in your digestive
system. These symptoms are generally mild, occur at the beginning of treatment and are particularly
experienced after meals containing high levels of fat. Normally, these symptoms disappear if you continue
treatment and keep to your recommended diet.
Very common side effects (may affect more than 1 in 10 people)
• headache
• upper respiratory tract infection
• abdominal pain/discomfort
• urgent or increased need to open the bowels
• flatulence (wind)
• flatulence (wind) with discharge
• oily discharge
• oily or fatty stools
• liquid stools
• increased elimination of stools
• influenza (‘flu’)
• low blood sugar levels (experienced by some people with type 2 diabetes).
Common side effects (may affect up to 1 in 10 people)
• lower respiratory tract infection
• rectal pain/discomfort
• soft stools
• faecal incontinence (inability to control your bowel movements)
• bloating (experienced by some people with type 2 diabetes)
• tooth/gum disorder
• urinary tract infection
• irregularity of menstrual cycle
• tiredness
• anxiety.
The following side effects have also been reported but their frequency cannot be estimated from the
available data:
• allergic reactions. The main symptoms are itching, rash, wheals (slightly elevated, itchy skin patches that
are paler or redder than surrounding skin), severe difficulty in breathing, nausea, vomiting and feeling
unwell. Contact your doctor immediately if you experience any of these
• bleeding from the back passage (rectum)
• increases in the levels of some liver enzymes may be found in blood tests
• diverticulitis (the most common symptom is abdominal pain. Cramping, nausea, vomiting, fever, chills,
or a change in bowel habits may also appear)
• gallstones
• hepatitis (inflammation of the liver). Symptoms can include yellowing skin and eyes, itching, dark
coloured urine, stomach pain and liver tenderness (indicated by pain under the front of the rib cage on
your right hand side), sometimes with loss of appetite
• skin blistering (including blisters that burst)
• effects on clotting with anti-coagulants
• pancreatitis (inflammation of the pancreas)
• oxalate nephropathy (build up of calcium oxalate which may lead to kidney stones). See section 2.
Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects
not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.
gov.uk/yellowcard
By reporting side effects you can help provide more information on the safety of this medicine.

5. HOW TO STORE BEACITA
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the packaging after “EXP”. The expiry date
refers to the last day of that month.
Do not store above 25ºC.
Store in the original package in order to protect from light and moisture.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw
away medicines you no longer use. These measures will help protect the environment.

6. CONTENTS OF THE PACK AND OTHER INFORMATION
What Beacita contains
• The active substance is orlistat. Each hard capsule contains 120mg of orlistat.
• The other ingredients are:
capsule filling: microcrystalline cellulose PH112, sodium starch glycolate (type A), sillica colloidal
anhydrous, sodium laurilsulfate;
capsule shell: gelatin, titanium dioxide (E171), indigo carmine (E132).
What Beacita looks like and contents of the pack
Beacita capsules are blue and are supplied in blister packs, containing 84 capsules.
Marketing authorisation holder
Actavis Group PTC ehf.
Reykjavíkurvegi 76-78
220 Hafnarfjörður
Iceland
Manufacturer
Pharmaceutical Works POLPHARMA SA
19 Pelplińska Street
83-200 Starogard Gdański
Poland
This leaflet was last approved in December 2015.

If you would like a leaflet with larger text, please contact 01271 385257.

Actavis, Barnstaple, EX32 8NS, UK

AAAI5716

Orlistat 120 mg Capsules PIL UK

1. black

item no:

AAAI5716

dimensions: 150 x 400

print proof no:

2

pharmacode:

origination date: 3.12.15
approved for print/date

colours/plates:

min pt size:

2.
3.
4.

8 pt

originated by:

db

revision date:

23.12.15

Technical Approval

revised by:

db

date sent:

3.12.15

supplier:

Farmaprojects

approved:

23.12.15

5.
6.
Non Printing Colours
1.
2.
3.

Expand view ⇕

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide